Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexe…
Industry Peers
Medical Care Facilities| Headline | Source | Time |
|---|---|---|
Yesterday | ||
![]() Here's Why You Should Hold PAYX Stock in Your Portfolio Now Paychex's growth outlook benefits from Paycor, expanding HCM offerings, AI adoption and strong cash flow, even as competition and cyber risks persist. | ||
This week | ||
![]() Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar CareDx, Healthcare Services Group, Forum Energy Technologies, Amneal Pharmaceuticals and Caterpillar emerge as high-efficiency stocks poised for stronger returns. | ||
![]() 5 Top-Ranked High-Efficiency Stocks Poised for Stronger Returns Five stocks, including CareDx and Caterpillar, cleared an efficiency screen based on key ratios exceeding industry averages. | ||
Older | ||
Are Business Services Stocks Lagging Healthcare Services Group (HCSG) This Year? Here is how Healthcare Services (HCSG) and Marsh (MRSH) have performed compared to their sector so far this year. | ||
Should Value Investors Buy Healthcare Services Group (HCSG) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | ||
Is Healthcare Services Group (HCSG) Fairly Priced Or Getting Stretched? Healthcare Services Group has delivered a strong 81.9% return over the past three years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples lean towards the stock being on the expensive side. Over three years, Healthcare Services Group has returned 81.9%, which puts recent share price weakness into the context of a longer period of solid gains. The company is emphasizing steady growth and has... | ||
Can Healthcare Services Group’s (HCSG) Mix of Buybacks and ESOP Issuance Redefine Its Capital Strategy? Earlier this week, Healthcare Services Group, Inc. reported second-quarter 2026 results showing higher sales of US$470.81 million and a swing to net income of US$22.7 million from a net loss a year earlier, while also completing a US$35.64 million buyback of 1,744,179 shares. Around the same time, the company filed a US$56.08 million shelf registration for 2,500,000 common shares tied to an ESOP offering, highlighting its use of both repurchases and employee ownership to shape its capital... | ||
Healthcare Services Group Inc (HCSG) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... Healthcare Services Group Inc (HCSG) reports robust Q2 2026 results with $470.8 million in revenue, while navigating food inflation and geopolitical uncertainties. | ||
Healthcare Services Group, Inc. Q2 2026 Earnings Call Summary Moby summary of Healthcare Services Group, Inc.'s Q2 2026 earnings call | ||
Healthcare Services Group Q2 Earnings Call Highlights Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company | ||
Healthcare Services (HCSG) Tops Q2 Earnings and Revenue Estimates Healthcare Services (HCSG) delivered earnings and revenue surprises of +60.00% and +0.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
Four Stocks Flash Technical Strength Amid Market Volatility; Offer Entries Tracking a stock's performance against a benchmark like the S&P 500 can pay off handsomely when that tracker hits new highs, revealing the names that are defying market volatility. Investor's Business Daily's stock screener for stocks with their Relative Strength at new highs shows four names that are near buy points in Monday's stock market. All four also have a Relative Strength Rating — which compares the stock with others in the IBD database — above 80. | ||
It's Not The Next Nvidia, But This Stock's Steady Climb Rewards Patient Investors The stock is a slow-and-steady stock performer banking on a robust outlook. Its earnings report is just days away. | ||


